Related Experiment Video
Updated: Aug 13, 2026
09:15
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
Kidney transplantation under FK 506
1Department of Surgery, University Health Center of Pittsburgh, PA 15213.
JAMA
|July 4, 1990
Summary
The immunosuppressive drug FK 506 shows promise in kidney transplant recipients, with high survival and dialysis-free rates. While FK 506 has potential side effects, they appear less severe than cyclosporine.
Area of Science:
- Nephrology
- Immunosuppression
- Transplantation Medicine
Background:
- The study investigates the efficacy and safety of FK 506, an experimental immunosuppressive drug.
- Many renal transplant recipients in the study were highly sensitized, indicating a challenging patient population.
Purpose of the Study:
- To evaluate the outcomes of renal transplant recipients treated with FK 506.
- To assess the safety profile and side effects of FK 506 compared to existing therapies.
Main Methods:
- 36 renal transplant recipients received FK 506.
- Patients included those undergoing retransplantation and multi-organ transplants.
- Follow-up ranged from 4 to 13 months.
Main Results:
- 81% of patients were dialysis-free with good renal function.
- Low incidence of cellular rejection (1 kidney lost), but high rate of humoral rejection in antibody-positive patients.
- FK 506 showed a low incidence of posttransplant hypertension and favorable effects on cholesterol and uric acid levels.
Conclusions:
- FK 506 demonstrates safety and efficacy in kidney transplantation, with potentially fewer side effects than cyclosporine.
- Further clinical trials of FK 506 in kidney transplantation are warranted.
- Humoral rejection remains a concern for antibody-positive patients.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...